Getinge AB (GNGBY)
21.52
+0.17
(+0.80%)
USD |
OTCM |
May 03, 16:05
Getinge Price to Book Value: 1.930 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.914 |
| May 01, 2024 | 1.901 |
| April 30, 2024 | 1.901 |
| April 29, 2024 | 1.958 |
| April 26, 2024 | 1.927 |
| April 25, 2024 | 1.891 |
| April 24, 2024 | 1.914 |
| April 23, 2024 | 1.923 |
| April 22, 2024 | 1.912 |
| April 19, 2024 | 1.742 |
| April 18, 2024 | 1.703 |
| April 17, 2024 | 1.753 |
| April 16, 2024 | 1.767 |
| April 15, 2024 | 1.748 |
| April 12, 2024 | 1.716 |
| April 11, 2024 | 1.784 |
| April 10, 2024 | 1.772 |
| April 09, 2024 | 1.833 |
| April 08, 2024 | 1.842 |
| April 05, 2024 | 1.771 |
| April 04, 2024 | 1.761 |
| April 03, 2024 | 1.755 |
| April 02, 2024 | 1.732 |
| April 01, 2024 | 1.775 |
| March 31, 2024 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.828 |
| March 27, 2024 | 1.855 |
| March 26, 2024 | 1.802 |
| March 25, 2024 | 1.821 |
| March 22, 2024 | 1.787 |
| March 21, 2024 | 1.786 |
| March 20, 2024 | 1.807 |
| March 19, 2024 | 1.829 |
| March 18, 2024 | 1.813 |
| March 15, 2024 | 1.872 |
| March 14, 2024 | 1.869 |
| March 13, 2024 | 1.888 |
| March 12, 2024 | 1.842 |
| March 11, 2024 | 1.836 |
| March 08, 2024 | 1.843 |
| March 07, 2024 | 1.830 |
| March 06, 2024 | 1.784 |
| March 05, 2024 | 1.775 |
| March 04, 2024 | 1.782 |
| March 01, 2024 | 1.823 |
| February 29, 2024 | 1.794 |
| February 28, 2024 | 1.802 |
| February 27, 2024 | 1.836 |
| February 26, 2024 | 1.844 |
| February 23, 2024 | 1.835 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.548
Minimum
Jun 26 2023
4.952
Maximum
Nov 15 2021
2.548
Average
2.263
Median
May 19 2023
Price to Book Value Benchmarks
| Abliva AB | 1.914 |
| Karolinska Development AB | 0.5938 |
| Calliditas Therapeutics AB | 15.33 |
| Oncopeptides AB | 1.961 |
| Olink Holding AB | 5.687 |
Price to Book Value Related Metrics
| PE Ratio | 27.21 |
| PS Ratio | 1.925 |
| Price to Free Cash Flow | 18.84 |
| Price | 21.52 |
| Earnings Yield | 3.67% |
| Market Cap | 5.861B |
| Operating PE Ratio | 15.51 |
| Normalized PE Ratio | 25.16 |